24 assets in Frontotemporal Dementia

Therapeutic assets addressing Frontotemporal Dementia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Flortaucipir Frontotemporal Dementia	Mayo Clinic	P4	BBB (73)
Fludeoxyglucose Frontotemporal Dementia	University of Michigan	P4	BB (68)
Lemborexant Frontotemporal Dementia	Nova Scotia Health Authority	P4	BB (65)
Pittsburgh Compound B Unlabelled Frontotemporal Dementia	Mayo Clinic	P4	BB (65)
Izaflortaucipir Frontotemporal Dementia	University of Pennsylvania	P3	BB (64)
Tpn-101 Frontotemporal Dementia	Transposon Therapeutics, Inc.	P2	B (57)
Metformin Frontotemporal Dementia	University of Florida	P2	CCC (53)
Nabilone Frontotemporal Dementia	Simon Ducharme, MD	P2	CCC (53)
Vortioxetine Frontotemporal Dementia	Johns Hopkins University	P2	CCC (53)
Intrathalamic Avb-101 Frontotemporal Dementia	AviadoBio Ltd	P1/2	CCC (48)
Umbilical Cord Derived Mesenchymal Stem Cells Exosomes Frontotemporal Dementia	Ruijin Hospital	P1/2	CCC (48)
Wve-004 Frontotemporal Dementia	Wave Life Sciences USA, Inc.	P1/2	CCC (48)
Alnugranogene Aldeparvovec Frontotemporal Dementia	Passage Bio, Inc.	P1/2	CC (47)
dnl593 Frontotemporal Dementia	Denali Therapeutics Inc.	P1/2	CC (47)
ly3884963 Frontotemporal Dementia	Prevail Therapeutics	P1/2	CC (47)
Prednisone Frontotemporal Dementia	Prevail Therapeutics	P1/2	CC (47)
Sirolimus Frontotemporal Dementia	Prevail Therapeutics	P1/2	CC (47)
Et-Stem Frontotemporal Dementia	Samsung Medical Center	P1	CC (43)
Huc-Msc-Sev-001 Nasal Drops Frontotemporal Dementia	Xuanwu Hospital, Beijing	P1	CC (43)
[18F]ACI-19626 Frontotemporal Dementia	AC Immune SA	Early P1	C (39)
NS101 Frontotemporal Dementia	Hee-Jin Kim	P2	NR ()
ves001 Frontotemporal Dementia	Mads Kjolby	P1	NR ()